Lam Research (LRCX) Misses Q2 EPS by 11c

Lam Research (NASDAQ: LRCX) reported Q2 EPS of $7.40, $0.11 worse than the analyst estimate of $7.51. Revenue for the quarter came in at $4.06 billion versus the consensus estimate of $4.25 billion.

GUIDANCE:

Lam Research sees Q3 2022 EPS of $6.50-$8.00, versus the consensus of $8.24. Lam Research sees Q3 2022 revenue of $3.9-4.5 billion, versus the consensus of $4.46 billion.

For earnings history and earnings-related data on Lam Research (LRCX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Lam Research plans $3B R&D expansion over five years
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c